Micozzi, A.; Luise, C.; Lisi, C.; Moleti, L.; Santilli, S.; Gentile, G.
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing Klebsiella pneumoniae for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia—An 8-Year Retrospective Observational Study. Antibiotics 2024, 13, 1017.
https://doi.org/10.3390/antibiotics13111017
AMA Style
Micozzi A, Luise C, Lisi C, Moleti L, Santilli S, Gentile G.
Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing Klebsiella pneumoniae for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia—An 8-Year Retrospective Observational Study. Antibiotics. 2024; 13(11):1017.
https://doi.org/10.3390/antibiotics13111017
Chicago/Turabian Style
Micozzi, Alessandra, Cristina Luise, Chiara Lisi, Luisa Moleti, Stefania Santilli, and Giuseppe Gentile.
2024. "Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing Klebsiella pneumoniae for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia—An 8-Year Retrospective Observational Study" Antibiotics 13, no. 11: 1017.
https://doi.org/10.3390/antibiotics13111017
APA Style
Micozzi, A., Luise, C., Lisi, C., Moleti, L., Santilli, S., & Gentile, G.
(2024). Benefits and Safety of Empiric Antibiotic Treatment Active Against KPC-Producing Klebsiella pneumoniae for Febrile Neutropenic Episodes in Colonized Children with Acute Leukemia—An 8-Year Retrospective Observational Study. Antibiotics, 13(11), 1017.
https://doi.org/10.3390/antibiotics13111017
